Bosko M Stojanovski, Bassem M Mohammed, Enrico Di Cera
{"title":"The Prothrombin-Prothrombinase Interaction.","authors":"Bosko M Stojanovski, Bassem M Mohammed, Enrico Di Cera","doi":"10.1007/978-3-031-58843-3_15","DOIUrl":null,"url":null,"abstract":"<p><p>The hemostatic response to vascular injury entails a sequence of proteolytic events where several inactive zymogens of the trypsin family are converted to active proteases. The cascade starts with exposure of tissue factor from the damaged endothelium and culminates with conversion of prothrombin to thrombin in a reaction catalyzed by the prothrombinase complex composed of the enzyme factor Xa, cofactor Va, Ca<sup>2+</sup>, and phospholipids. This cofactor-dependent activation is paradigmatic of analogous reactions of the blood coagulation and complement cascades, which makes elucidation of its molecular mechanism of broad significance to the large class of trypsin-like zymogens to which prothrombin belongs. Because of its relevance as the most important reaction in the physiological response to vascular injury, as well as the main trigger of pathological thrombotic complications, the mechanism of prothrombin activation has been studied extensively. However, a molecular interpretation of this mechanism has become available only recently from important developments in structural biology. Here we review current knowledge on the prothrombin-prothrombinase interaction and outline future directions for the study of this key reaction of the coagulation cascade.</p>","PeriodicalId":21991,"journal":{"name":"Sub-cellular biochemistry","volume":"104 ","pages":"409-423"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sub-cellular biochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-031-58843-3_15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
The hemostatic response to vascular injury entails a sequence of proteolytic events where several inactive zymogens of the trypsin family are converted to active proteases. The cascade starts with exposure of tissue factor from the damaged endothelium and culminates with conversion of prothrombin to thrombin in a reaction catalyzed by the prothrombinase complex composed of the enzyme factor Xa, cofactor Va, Ca2+, and phospholipids. This cofactor-dependent activation is paradigmatic of analogous reactions of the blood coagulation and complement cascades, which makes elucidation of its molecular mechanism of broad significance to the large class of trypsin-like zymogens to which prothrombin belongs. Because of its relevance as the most important reaction in the physiological response to vascular injury, as well as the main trigger of pathological thrombotic complications, the mechanism of prothrombin activation has been studied extensively. However, a molecular interpretation of this mechanism has become available only recently from important developments in structural biology. Here we review current knowledge on the prothrombin-prothrombinase interaction and outline future directions for the study of this key reaction of the coagulation cascade.
血管损伤后的止血反应包括一连串的蛋白水解事件,在这些事件中,胰蛋白酶家族的几种非活性酶原被转化为活性蛋白酶。这一级联反应始于受损内皮中组织因子的暴露,最终在由 Xa 因子酶、辅助因子 Va、Ca2+ 和磷脂组成的凝血酶原酶复合物催化的反应中,凝血酶原转化为凝血酶。这种依赖于辅助因子的活化是血液凝固和补体级联类似反应的典范,因此阐明其分子机制对凝血酶原所属的一大类胰蛋白酶样酶具有广泛意义。由于凝血酶原是血管损伤生理反应中最重要的反应,也是病理血栓并发症的主要诱因,因此人们对凝血酶原的活化机制进行了广泛的研究。然而,对这一机制的分子解释直到最近才从结构生物学的重要发展中获得。在此,我们回顾了目前有关凝血酶原-凝血酶原酶相互作用的知识,并概述了凝血级联这一关键反应的未来研究方向。
期刊介绍:
The book series SUBCELLULAR BIOCHEMISTRY is a renowned and well recognized forum for disseminating advances of emerging topics in Cell Biology and related subjects. All volumes are edited by established scientists and the individual chapters are written by experts on the relevant topic. The individual chapters of each volume are fully citable and indexed in Medline/Pubmed to ensure maximum visibility of the work.